INTRODUCTION
============

MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene silencing (PTGS) that is a highly-conserved mechanism for regulating gene expression. miRNAs inhibit protein synthesis by binding with the 3\'UTR or, rarely, the coding sequence of specific mRNAs ([@B1]).

miRNAs are known to be involved in several physiological processes, such as apoptosis, development and cell differentiation, and their aberrant expression is observed in several diseases such as cancer, neurodegeneration and cardiac pathologies ([@B9]).

miRNAs are also expressed by viruses (v-miRNAs), which may act as self-regulators. It has been shown that the EBV-encoded miRNA, miR-BART2, down-regulates the viral DNA polymerase BALF5, thus inhibiting transition from latent to lytic viral replication ([@B2]). v-miRNAs can also interference with the host cell transcripts ([@B4]). The cellular protein p53, an up-regulated modulator of apoptosis (PUMA), is regulated by the EBV-encoded miR-BART5. The expression of miR-BART5 renders infected miR-BART5-expressing cells less sensitive to pro-apoptotic agents, but apoptosis can be triggered by depleting miR-BART5 or inducing the expression of PUMA. This shows the capability of v-miRNAs to facilitate the establishment of latent infection by promoting host cell survival ([@B6]).

The silencing of some nodes of the apoptotic pathway would give to the virus an important advantage during its lysogenic phase, since the host cells would not die by cell death triggered from infection and the virus could complete its vital cycle. Many v-miRNAs are located in proximity or inside viral latency genes and, presumably, co-transcribed with them ([@B23]). On the other hand, in many cases of viral infection the activation of apoptosis is needed during the lytic cycle of the virus allowing the processing of capsides and viral particles dissemination ([@B22]).

The negative and positive modulation of the apoptotic process is a fundamental activity for beginning and concluding the vital cycle of the virus. The above mentioned cases and other recent findings show that, besides well-known protein mechanisms of apoptosis control by viruses, there are other strategies of apoptosis regulation based on translational repression by miRNAs ([@B20]).

Apoptosis may also represent one of the most important links between viral infections and oncogenesis. All tumor related viruses seem to share the same approach to interfere with apoptosis and cell-cycle genes ([@B8]). Thus, they may directly promote neoplastic transformation of infected cells or facilitate cancer insurgence in favourable contexts. For example, the Kaposi Sarcoma Herpes Virus encodes a protein called LANA, which inhibits the tumor suppressor protein p53, thus promoting cell survival, virus latency and oncogenesis ([@B30]).

In this article we present computational predictions of human targets for v-miRNAs encoded by two tumor related viruses, Epstein-Barr Virus (EBV) and Kaposi Sarcoma Herpes Virus (KSHV). The predictions are computed by a novel approach, which combines thermodynamics and empirical constraints in order to produce reliable miRNA/target duplexes.

Our results demonstrate v-miRNA/human target pairs which possess good binding scores, some of which are also supported by publicly available data on gene expression profiles. These findings are consistent with previously reported regulation mechanisms and offer a set of candidate targets for further biological validation.

MATERIALS AND METHODS
=====================

Computational prediction of v-miRNA/target duplexes
---------------------------------------------------

v-miRNAs/human target interactions were predicted by miRiam, a novel tool capable of screening large databases of miRNAs in order to identify the most probable binding sites on a given mRNA, in a reasonable time. miRiam is based on a combined approach which makes use of thermodynamics and pairing constraints inferred from known miRNA/target pairs.

The importance of target secondary structure in miRNA-based silencing has been previously demonstrated ([@B29]). Target binding sites must be accessible and interactions with miRNAs have to be energetically favourable ([@B18]). Moreover, to predict duplexes reliably several features inferred from known miRNA/mRNA pairs need to be taken into account. For example, miRNA 5\'end contains the seed region, which is important in their binding with the target using near perfect complementarity. Nevertheless, the seed region may sometimes contain G:U wobbles, and the number of G:U wobbles in this region appears to be inversely related to silencing efficacy of the miRNA. Almost all known miRNA binding sites are located in the 3\' UTRs of target mRNAs, and multiple binding sites have been observed in several cases, potentially increasing the efficacy of silencing ([@B11]).

Given a target mRNA sequence and a database of miRNAs, which can be retrieved from miRBase, miRiam performs the following steps:

i.  *Target accessibility evaluation*: Base pairing probabilities of the target are computed by Vienna RNA package functions ([@B13]) and used to identify accessible regions, *i.e*. less paired sub-sequences.

ii. *Alignment of miRNA/binding sites:* The complementary base-pair alignment of accessible sub-sequences with miRNAs is then computed. A variant of the classical Needleman-Wunsch pairwise sequence alignment in which only matches of complementary base pairs are allowed is used.

iii. *Post alignment filtering*: All duplexes which do not satisfy previously described empirical sequence constraints are discarded. The remaining pairs are presented to the user ordered by their binding energies.

miRNAs and targets selection
----------------------------

EBV and KSHV miRNAs were obtained from miRBase ([@B10]). Target mRNA transcripts were downloaded from GenBank, chosen based on their Gene Ontology annotations. Genes annotated with the following terms were selected: Pro-apoptosis, cell cycle arrest, cell cycle checkpoint, negative regulation of cell cycle, negative regulation of cyclin-dependent kinase activity, and negative regulation of mitotic cell cycle.

Expression data
---------------

The expression profiles of the predicted targets were retrieved from the NCBI GEO Profiles database. Among the available datasets, NCBI GDS940 and GDS989 were selected as they were obtained from suitable biological specimens (infected cells and corresponding uninfected controls). For each predicted target, experiments performed on EBV and KSHV infected cells were selected and the ratios between the mean gene expression values in the infected and in the control samples were computed. The evaluation of fold change significance using formal statistical methods was not possible due to the small number of available samples. For this reason the observed ratios should be considered as qualitative descriptors supporting or confuting the proposed hypotheses. The data on the v-miRNA expressing tissues were obtained from the literature ([@B25]; [@B26]; [@B4]; [@B4]; [@B19]; [@B21]; [@B31]) and from the miR-Z database ([@B12]).

RESULTS
=======

Representative results of our predictions are shown in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. [Table 1](#T1){ref-type="table"} contains the EBV miRNAs predicted targets while [Table 2](#T2){ref-type="table"} shows the predictions for KSHV miRNAs. For each v-miRNA, the tissues where it is expressed, the predicted human targets and. Only the transcripts with perfect matches with the seed of v-miRNAs in structurally-accessible regions were selected (maximum one G:U wobble allowed in the seed region). These results indicate the putative capability of EBV and KSHV to interfere with the expression of host genes involved in apoptosis and cell cycle regulation. Moreover, some of the predictions are supported by gene expression profiles in EBV and KSHV infected cells.

###### 

Predicted targets for EBV v-miRNAs. For each miRNA, the list of tissues where it is expressed, the predicted targets, the number of site on each target transcript and the associated ontological term are given. Tissues legend: AML: Acute myeloid leukemia, BCLL: B-Chronic lymphocytic leukemia, BL: Burkitt\'s lymphoma, ESC: Embryonic stem cells, GC: Gastric carcinoma, HD: Hodgkin\'s disease, L: Lymphoblasts, LAC: Lung\'s adenocarcinoma, LBCL: Large B-cell lymphoma, LU: Lung, MCL: Mantle cell lymphoma, M: Myeloblasts, NC: Nasopharyngeal carcinoma, PEL: Primary-effusion lymphoma, USSC: Unrestricted somatic stem cells.

  v-miRNA         Tissues                                                  Target                                                    Sites   Target\'s GO terms
  --------------- -------------------------------------------------------- --------------------------------------------------------- ------- -----------------------------------
  miR-BART3-3p    BCLL, BL, HG, L, LBCL, MCL                               CASP10                                                    1       Pro-Apoptosis
  miR-BART6-3p    BCLL, BL, HG, L, LBCL, MCL, NC                           BAD                                                       1       Pro-Apoptosis
  miR-BART7       AML, BCLL, BL, ESC, GC, HG, LBCL, MCL, USSC              RB1                                                       1       Negative regulation of cell cycle
  miR-BART9       BCLL, BL, HG, MCL                                        RAD1                                                      2       Cell cycle checkpoint
  RB1             1                                                        Negative regulation of cell cycle                                 
  miR-BART10      BCLL, BL, GC, HG, MCL                                    ZAK                                                       1       Cell cycle arrest
  miR-BART11-5p   BCLL, BL, HG, L, NC                                      CASP3                                                     1       Pro-Apoptosis
  miR-BART11-3p   BCLL, BL, HG, L, MCL, NC                                 TP53                                                      1       Regulation of cell cycle
  miR-BART12      BCLL, BL, GC, NC, PEL                                    TP53                                                      1       Regulation of cell cycle
  miR-BART13      BCLL, BL, HG, L, MCL                                     CASP3                                                     1       Pro-Apoptosis
  APC             2                                                        Negative Regulation of cyclin-dependent kinase activity           
  miR-BART15      BCLL, BL, HG, MCL                                        CASP3                                                     1       Pro-Apoptosis
  miR-BART16      BCLL, BL, HG, L, MCL                                     BID                                                       1       Pro-Apoptosis
  miR-BART19      BL, HG, MCL                                              APBB2                                                     2       Cell cycle arrest
  ZAK             1                                                        Cell cycle arrest                                                 
  STK4            2                                                        Pro-Apoptosis                                                     
  miR-BART20-3p   BCLL, BL, L                                              BAX                                                       1       Pro-Apoptosis
  miR-BHRF1-1     BCLL, BL, HG, L, MCL                                     CUL4                                                      2       Cell cycle arrest
  miR-BHRF1-2     AML, BCLL, BL, ESC, HG, L, LBCL, M, MCL, LAC, LU, USSC   RAD1                                                      1       Cell cycle checkpoint
  miR-BHRF1-2\*   \-                                                       CCNG2                                                     1       Cell cycle checkpoint
  GAS1            2                                                        Cell cycle arrest                                                 
  RB1             2                                                        Negative regulation of cell cycle                                 
  miR-BHRF1-3     BCLL, BL, HG, L, LBCL, MCL                               BID                                                       1       Pro-Apoptosis

###### 

Predicted targets for KSHV v-miRNAs. For each miRNA, the list of tissues where it is expressed, the predicted targets, the number of site on each target\'s transcript and the GO term associated to the targets are shown. Tissues legend: BCBL: Body cavity-based lymphoma, BL: Burkitt\'s lymphoma, PEL: Primary-effusion lymphoma.

  v-miRNA        Tissues         Target                                                    Sites   Target\'s GO terms
  -------------- --------------- --------------------------------------------------------- ------- ---------------------------------------------------------
  miR-K12-1      BCBL, BL, PEL   RBL1                                                      1       Negative regulation of cell cycle
  RAD1           1               Cell cycle checkpoint                                             
  miR-K12-2      BCBL, BL, PEL   CASP10                                                    1       Pro-Apoptosis
  APC            2               Negative Regulation of cyclin-dependent kinase activity           
  RAD1           1               Cell cycle checkpoint                                             
  miR-K12-3      BCBL, BL, PEL   APC                                                       1       Negative Regulation of cyclin-dependent kinase activity
  STK4           3               Pro-Apoptosis                                                     
  miR-K12-4-5p   BCBL, BL, PEL   RBL1                                                      1       Negative regulation of cell cycle
  ZAK            1               Cell cycle arrest                                                 
  miR-K12-6-3p   BCBL, BL, PEL   BID                                                       1       Pro-Apoptosis
  BTG3           1               Negative Regulation of mitotic cell cycle                         
  miR-K12-9\*    BCBL, BL, PEL   CASP8                                                     1       Pro-Apoptosis
  TP53           1               Regulation of cell cycle                                          
  miR-K12-10a    BCBL, BL, PEL   CASP10                                                    1       Pro-Apoptosis
  miR-K12-11     BL              RB1                                                       1       Negative regulation of cell cycle
  RBL1           1               Negative regulation of cell cycle                                 
  APC            3               Negative Regulation of cyclin-dependent kinase activity           
  miR-K12-12     PEL             CASP10                                                    1       Pro-Apoptosis

[Table 3](#T3){ref-type="table"} shows, for each predicted target, the ratios between the mean expression values in the infected and control cells. A value less than 1 indicates that the gene is under-expressed in the infected samples, compared to the control cells. Only these values are reported, since they are the significant ones concerning our analysis. The complete data are given in supplementary tables ([Tables S1](#SD1){ref-type="supplementary-material"}-[S3](#SD3){ref-type="supplementary-material"}).

###### 

Expression profiles of the predicted targets in infected cells. The profiles were retrieved from the NCBI GEO Profiles database. For each target, the GEO record ID, the virus, the mean value in the control sample (not infected), the mean value in the infected cell and the infected/control ratio are shown. Only values less than 1 are reported, since they indicate that the gene is under-expressed in the infected sample, compared to the control cell.

  Gene                    GEO Record              Virus     Mean (Control)   Mean (Infected)   Ratio (I/C)
  ----------------------- ----------------------- --------- ---------------- ----------------- -------------
  ABL1                    GDS989 - 1636_g\_at     EBV       5928.75          3531.80           0.59
  GDS989 - 39730_at       EBV                     5839.95   3504.20          0.60              
  GDS989 - 1635_at        EBV                     2786.60   1428.30          0.51              
  GDS940 - 202123_s\_at   KSHV                    406.35    246.35           0,60              
  APC                     GDS940 - 203525_s\_at   KSHV      110.60           63.90             0.57
  BID                     GDS940 - 204493_at      KSHV      263.25           140.40            0.53
  BTG3                    GDS940 - 213134_x\_at   KSHV      471.05           233.25            0.49
  CCNG2                   GDS989 - 1913_at        EBV       2690.40          1679.80           0.62
                          GDS940 - 211559_s\_at   KSHV      109.65           98.55             0.89
  RAD1                    GDS989 - 36857_at       EBV       2365.45          1954.6            0.82
  GDS940 - 204461_x\_at   KSHV                    176.50    77.55            0.43              
  GDS940 - 204460_s\_at   KSHV                    136.75    73.85            0.54              
  GDS940 - 210216_x\_at   KSHV                    158.55    102.85           0.64              
  RB1                     GDS989 - 2044_s\_at     EBV       1307.35          1149.60           0.87
  GDS940 - 203132_at      KSHV                    157.80    140.90           0.89              
  SMAD3                   GDS940 - 205398_s\_at   KSHV      314.75           157.80            0.50
  STK4                    GDS940 - 211085_s\_at   KSHV      19.65            12.10             0.61
  TP53                    GDS989 - 1974_s\_at     EBV       1712.40          1561.70           0.91
  GDS989 - 1974_s\_at     KSHV                    1712.40   1530.25          0.89              
  GDS940 - 201746_s\_at   KSHV                    405.70    370.00           0.91              
  ZAK                     GDS940 - 218833_at      KSHV      42.50            30.25             0.71

Finally, in order to assess the reliability of the proposed method, we performed a comparison between miRiam and some of the most popular available tools for miRNA target prediction: RNA Hybrid, miRanda, RNA22 and PITA ([@B28]; [@B15]; [@B14]). For this purpose, we chose a set of validated v-miRNA/human targets for which binding sites details were available. Results are reported on [Table 4](#T4){ref-type="table"}. They show the capability of miRiam to identify all the validated binding sites, in most cases as top ranking. We evaluated the statistical significance of our results by the Friedman rank test. While miRiam is comparable to PITA, in terms of number of correct sites identified, it outperforms the other tools in terms of the number of correct binding sites and their ranking.

###### 

Comparison of miRiam to other target prediction tools. We chose a set of validated v-miRNA/human targets for which binding sites details were available. For each tested tool, the ranking of the site in the output is reported. A "-" symbol indicates that the tool wasn\'t able to identify the site. P-values are computed by using the Friedman Rank Test, to assess whether or not miRiam significantly tends to perform better than the other tools across experimentally validated targets. Results show that miRiam performs better than RNA Hybrid, miRanda and RNA22, while is comparable to PITA.

  Virus   mIRNA         Target   Transcript       Site         miRiam                               RNAHybrid   miRanda    RNA22           PITA
  ------- ------------- -------- ---------------- ------------ ------------------------------------ ----------- ---------- --------------- ------
  KSHV    miR-K12-11    BACH-1   NM_001186.2      3156-3162    2                                    2           \-         \-              3
  KSHV    miR-K12-11    BACH-1   NM_001186.2      4504-4511    3                                    \-          \-         \-              2
  KSHV    miR-K12-11    BACH-1   NM_001186.2      4565-4571    1                                    \-          \-         \-              1
  KSHV    miR-K12-11    BACH-1   NM_001186.2      4714-4720    4                                    \-          \-         \-              7
  KSHV    miR-K12-11    BACH-1   NM_206866.1      3284-3290    2                                    3           \-         \-              3
  KSHV    miR-K12-11    BACH-1   NM_206866.1      4632-4639    3                                    \-          \-         \-              2
  KSHV    miR-K12-11    BACH-1   NM_206866.1      4693-4699    1                                    \-          \-         \-              1
  KSHV    miR-K12-11    BACH-1   NM_206866.1      4842-4848    4                                    \-          \-         \-              7
  HCMV    miR-UL112-1   MICB     NM_005931.3      1319-1323    16[\*](#TFN4){ref-type="table-fn"}   1           2          \-              \-
  EBV     miR-BART5     BBC3     NM_001127240.1   1366-1372    1                                    1           1          \-              1
  EBV     miR-BART5     BBC3     NM_001127241.1   1147-1153    1[\*](#TFN4){ref-type="table-fn"}    1           1          \-              1
  EBV     miR-BART5     BBC3     NM_001127242.1   956-962      1[\*](#TFN4){ref-type="table-fn"}    1           1          \-              1
  EBV     miR-BART5     BBC3     NM_014417.3      1450-1456    1                                    1           1          \-              1
  KSHV    miR-K5        BCLAF1   NM_014739.2      5301-5308    1                                    10          \-         2               3
  KSHV    miR-K5        BCLAF1   NM_001077440.1   5148-5155    1                                    9           \-         2               3
  KSHV    miR-K5        BCLAF1   NM_001077441.1   4782-4789    1                                    10          \-         2               3
                                                  *p-values*   \-                                   **0.05**    **0.03**   **\< 0.0001**   0.25

\*miRiam was able to identify these sites by relaxing the structural accessibility filter.

DISCUSSION
==========

v-miRNAs vs human targets
-------------------------

Epstein Barr herpesvirus (EBV) is associated with several tumor types, such as Burkitt\'s lymphoma, nasopharyngeal and gastric carcinoma ([@B8]). EBV expresses two families of miRNAs, which are located in the BART and BHRF1 genes ([@B25]; [@B4]). The BHRF1 miRNAs are expressed in infected primary lymphoma, Burkitt\'s lymphoma and lymphoblast cell lines during late latency and lytic stages, while BART members are always expressed in lymphoblasts in all latent stages. miR-BART12 has also been found in infected nasopharyngeal and gastric carcinoma cell lines ([@B19]).

Kaposi\'s sarcoma-associated herpesvirus (KSHV) is associated with several forms of cancer like Kaposi\'s sarcoma and primary effusion lymphomas ([@B8]). KSHV expresses an array of 13 miRNAs in infected primary effusion lymphoma and endothelial cell lines ([@B25]; [@B18]). miR-BHRF1-3, miR-BART16 in EBV and miR-K12-6-3p in KSHV show good matches to BID transcript. Moreover, BID mRNA levels decrease after viral infection. The BID silencing could cause the partial block of the connection between the extrinsic apoptotic pathway and the mitochondrial one. BID is a target of proteolytic activity of CASP8, which is activated by cell surface death receptors. Truncated BID translocates in the mitochondria engaging BAX to trigger its pro-apoptotic activity, starting the release of the cytochrome c. This is a key event in the formation of the apoptosoma complex (cytochrome c, APAF1 and CASP9) for the beginning of the intrinsic death pathway. Consequently, BID inhibition may lower cell sensitivity to external signals and promote resistance to apoptosis. Moreover, it has been shown that BHRF, the host gene of these miRNAs, encodes a protein which acts downstream of BID cleavage and upstream of mitochondrial damage, resulting in inhibition of TRAIL-induced apoptosis ([@B17]). This makes plausible a function of these miRNAs as repressors of apoptosis.

TP53 is a predicted target for EBV miR-BART11-3p, miR-BART12 and KSHV miR-K12-9\*. In particular two different favorable binding sites for both EBV-miRBART12 and KSHV-miR-K12-9\* have been identified in TP53 transcript. We also observed a significant decrease in TP53 transcript levels following EBV and KSHV infections (see [Table 3](#T3){ref-type="table"}). The presence of multiple binding sites for the same miRNA has been observed in several experimentally validated pairs. This potentially increases the degree of translational suppression. TP53 is an important regulator of cell cycle arrest, apoptosis, and cellular senescence and it may be activated by various forms of cellular stress, as viral infection. Several reports provide evidence of how TP53 is involved in antiviral activity and how viruses in their infection strategy lead to protein inactivation of TP53 ([@B30]; [@B24]). That being so, a further repression device of TP53 based on RNA Interference from viruses looks plausible. Moreover, some data suggest that functional TP53 can promote the lytic cycle of some viruses. Consequently a repression strategy controlled by viral microRNAs could be an efficient and inexpensive switch on / off system of TP53 activities.

Our data suggest that Cyclin G2 (CCNG2) could be target of miRNAs from both EBV and KSHV. This pro-apoptotic protein has been found to be downregulated in many different tumours ([@B5]), and a decrease in its activity has been associated with improved proliferation. Its key role in cell-cycle and cell plasticity in cancer is underlined by the observation that the therapeutic effect of rapamicyn is also exerted through the enhancement of its transcription rate ([@B16]).

The ability to interfere with tp53 pathway through the post transcriptional regulation of some of its fundamental components (tp53, BID, cyclin g2) may constitute a mechanism to tightly and efficiently control the host survival rate improving replication and diffusion of viral progeny. Similarly, other genes involved in apoptosis and in the regulation of cell cycle, BAD, BTG3, BAX, RAD1, ZAK and RB1, among others, are predicted to be targets of EBV and KSHV miRNAs. The repression of these genes may help the virus to gain control of the host cells, thus favoring the accomplishment of the viral life cycle.

v-miRNAs involvement in cancer
------------------------------

Viruses are often involved in cancer development. They may directly promote cell malignancy or facilitate the progression of already established tumors ([@B8]). While protein based mechanisms of interaction between virus and hosts have been widely described, a direct involvement of v-miRNAs in cancer is not yet demonstrated. However, since experimental evidences show the capability of v-miRNAs to perturb host genes expression ([@B2]; [@B20]), their contribution to tumor insurgence is plausible. Moreover, a miRNA based host regulation system may represent a faster way for viruses to counteract cellular response to infection promoting their latency. According to Pfeffer and Voinnet ([@B25]), v-miRNAs could act as direct oncogenes or indirectly promote cancer development and diffusion, by supporting external etiologic agents.

The predictions presented in this study are consistent with these scenarios. In particular the inhibition of central nodes of the apoptotic pathways may lead to loss of cell cycle control by the cell itself.

CONCLUSIONS
===========

The aim of this work was to produce a set of plausible hypotheses of involvement of v-miRNAs and human apoptosis genes in cancer development. In the study, we have presented computational predictions of v-miRNAs and human targets interactions, and show miRNA/target duplexes which were energetically favourable and consistent with other experimentally validated pairs. Moreover, the target binding sites were characterized by high structural-accessibility for interactions with miRNAs. Future works will focus on providing experimental validations of such estimated interactions. Extension of predictions to other reasonable human transcripts, such as additional nodes of apoptosis pathway, cell-cycle regulators and genes involved in immune response, will be performed.

Supplementary Table S1.. Predicted targets for EBV v-miRNAs. For each miRNA, the list of tissues where it is expressed, the predicted targets, the number of site on each target\'s transcript and the GO term associated to the targets are shown. Tissues legend: AML: Acute myeloid leukemia, BCLL: B-Chronic lymphocytic leukemia, BL: Burkitt\'s lymphoma, ESC: Embryonic stem cells, GC: Gastric carcinoma, HD: Hodgkin\'s disease, L: Lymphoblasts, LAC: Lung\'s adenocarcinoma, LBCL: Large B-cell lymphoma, LU: Lung, MCL: Mantle cell lymphoma, M: Myeloblasts, NC: Nasopharyngeal carcinoma, PEL: Primary-effusion lymphoma, USSC: Unrestricted somatic stem cells. {#SD1}
==============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================

  v-miRNA         Tissues                                                  Target                                                    Sites   Target\'s GO terms
  --------------- -------------------------------------------------------- --------------------------------------------------------- ------- ---------------------------------------------------------
  miR-BART1-5p    BCLL, BL, HG, MCL                                        APC                                                       1       Negative Regulation of cyclin-dependent kinase activity
  CUL2            1                                                        Cell cycle arrest                                                 
  TBRG1           1                                                        Cell cycle arrest                                                 
  miR-BART2       BCLL, BL, HG, MCL                                        CDKN2A                                                    1       Negative Regulation of cyclin-dependent kinase activity
  CDKN2B          1                                                        Cell cycle arrest                                                 
  CUL3            1                                                        Pro-Apoptosis                                                     
  miR-BART3-3p    BCLL, BL, HG, L, LBCL, MCL                               CASP10                                                    1       Pro-Apoptosis
  miR-BART5       BCLL, BL, HG, MCL                                        AIFM2                                                     1       Pro-Apoptosis
  DAPK1           1                                                        Pro-Apoptosis                                                     
  miR-BART6-5p    BCLL, BL, HG, LBCL, MCL                                  GAS7                                                      1       Cell cycle arrest
  miR-BART6-3p    BCLL, BL, HG, L, LBCL, MCL, NC                           BAD                                                       1       Pro-Apoptosis
  miR-BART7       AML, BCLL, BL, ESC, GC, HG, LBCL, MCL, USSC              CASP6                                                     1       Pro-Apoptosis
  CUL3            1                                                        Pro-Apoptosis                                                     
  EIF4G2          1                                                        Cell cycle arrest                                                 
  FOXO4           1                                                        Cell cycle arrest                                                 
  RB1             1                                                        Negative regulation of cell cycle                                 
  TRAF3           1                                                        Pro-Apoptosis                                                     
  miR-BART8-3p    AML, BCLL, BL, HG, LBCL, MCL                             APBB2                                                     1       Cell cycle arrest
  EIF4G2          1                                                        Cell cycle arrest                                                 
  FEM1B           1                                                        Pro-Apoptosis                                                     
  GAS1            1                                                        Cell cycle arrest                                                 
  SIPA1           1                                                        Negative regulation of cell cycle                                 
  TP53BP2         1                                                        Negative regulation of cell cycle                                 
  miR-BART9       BCLL, BL, HG, MCL                                        RAD1                                                      2       Cell cycle checkpoint
  RB1             1                                                        Negative regulation of cell cycle                                 
  APBB2           1                                                        Cell cycle arrest                                                 
  STK3            1                                                        Pro-Apoptosis                                                     
  miR-BART10      BCLL, BL, GC, HG, MCL                                    CDKN2C                                                    1       Cell cycle arrest
  CUL5            1                                                        Cell cycle arrest                                                 
  ZAK             1                                                        Cell cycle arrest                                                 
  miR-BART11-5p   BCLL, BL, HG, L, NC                                      CASP3                                                     1       Pro-Apoptosis
  CUL2            1                                                        Cell cycle arrest                                                 
  miR-BART11-3p   BCLL, BL, HG, L, MCL, NC                                 TP53                                                      1       Regulation of cell cycle
  miR-BART12      BCLL, BL, GC, NC, PEL                                    TP53                                                      1       Regulation of cell cycle
  APBB2           1                                                        Cell cycle arrest                                                 
  miR-BART13      BCLL, BL, HG, L, MCL                                     APC                                                       2       Negative Regulation of cyclin-dependent kinase activity
  CASP3           1                                                        Pro-Apoptosis                                                     
  CDKN2B          1                                                        Cell cycle arrest                                                 
  MAPK1           1                                                        Pro-Apoptosis                                                     
  miR-BART14-3p   BCLL, BL, HG, MCL                                        ABL1                                                      1       Pro-Apoptosis
  BCL211          1                                                        Pro-Apoptosis                                                     
  CDKN2D          1                                                        Cell cycle arrest                                                 
  DIABLO1         1                                                        Pro-Apoptosis                                                     
  PAWR            1                                                        Pro-Apoptosis                                                     
  STK4            1                                                        Pro-Apoptosis                                                     
  miR-BART15      BCLL, BL, HG, MCL                                        CASP3                                                     1       Pro-Apoptosis
  CUL3            1                                                        Pro-Apoptosis                                                     
  CUL5            1                                                        Cell cycle arrest                                                 
  DAPK1           1                                                        Pro-Apoptosis                                                     
  miR-BART16      BCLL, BL, HG, L, MCL                                     BID                                                       1       Pro-Apoptosis
  CIDEB           1                                                        Pro-Apoptosis                                                     
  DHCR24          1                                                        Cell cycle arrest                                                 
  miR-BART17-3p   BCLL, BL, MCL                                            BOK                                                       1       Pro-Apoptosis
  TRAF3           1                                                        Pro-Apoptosis                                                     
  miR-BART18      BCLL, BL, HG, MCL                                        APC                                                       1       Negative Regulation of cyclin-dependent kinase activity
  LTA             1                                                        Pro-Apoptosis                                                     
  miR-BART19      BL, HG, MCL                                              APBB2                                                     2       Cell cycle arrest
  APC             1                                                        Negative Regulation of cyclin-dependent kinase activity           
  BTG4            1                                                        Cell cycle arrest                                                 
  CDKN2C          1                                                        Cell cycle arrest                                                 
  IFNW1           1                                                        Cell cycle arrest                                                 
  MAPK1           1                                                        Pro-Apoptosis                                                     
  MPHOSPH1        1                                                        Cell cycle arrest                                                 
  NLRP1           1                                                        Pro-Apoptosis                                                     
  STK4            2                                                        Pro-Apoptosis                                                     
  TNFRSF25        1                                                        Pro-Apoptosis                                                     
  ZAK             1                                                        Cell cycle arrest                                                 
  miR-BART20-3p   BCLL, BL, L                                              APC                                                       1       Negative Regulation of cyclin-dependent kinase activity
  BAX             1                                                        Pro-Apoptosis                                                     
  CDKN1B          1                                                        Pro-Apoptosis                                                     
  DHCR24          1                                                        Cell cycle arrest                                                 
  ERN1            1                                                        Cell cycle arrest                                                 
  NDUFA13         1                                                        Pro-Apoptosis                                                     
  RUNX3           1                                                        Negative regulation of cell cycle                                 
  miR-BHRF1-1     BCLL, BL, HG, L, MCL                                     BCL211                                                    1       Pro-Apoptosis
  BIK             1                                                        Pro-Apoptosis                                                     
  CUL4A           2                                                        Cell cycle arrest                                                 
  EI24            1                                                        Pro-Apoptosis                                                     
  LATS2           1                                                        Negative Regulation of cyclin-dependent kinase activity           
  MAPK1           2                                                        Pro-Apoptosis                                                     
  TRAF3           1                                                        Pro-Apoptosis                                                     
  miR-BHRF1-2     AML, BCLL, BL, ESC, HG, L, LBCL, M, MCL, LAC, LU, USSC   CUL1                                                      1       Cell cycle arrest
  RAD1            1                                                        Cell cycle checkpoint                                             
  miR-BHRF1-2\*   \-                                                       APC                                                       1       Negative Regulation of cyclin-dependent kinase activity
  BNIP3           1                                                        Pro-Apoptosis                                                     
  CCNG2           1                                                        Cell cycle checkpoint                                             
  CUL1            1                                                        Cell cycle arrest                                                 
  CUL3            1                                                        Pro-Apoptosis                                                     
  DAXX            1                                                        Pro-Apoptosis                                                     
  DEDD            1                                                        Pro-Apoptosis                                                     
  DIABLO          1                                                        Pro-Apoptosis                                                     
  ERN1            1                                                        Cell cycle arrest                                                 
  FOXO3A          1                                                        Pro-Apoptosis                                                     
  GAS1            2                                                        Cell cycle arrest                                                 
  ING4            1                                                        Cell cycle arrest                                                 
  RB1             2                                                        Negative regulation of cell cycle                                 
  STK4            1                                                        Pro-Apoptosis                                                     
  TSPYL2          1                                                        Negative regulation of cell cycle                                 
  miR-BHRF1-3     BCLL, BL, HG, L, LBCL, MCL                               BID                                                       1       Pro-Apoptosis

Supplementary Table S2.. Predicted targets for KSHV v-miRNAs. For each miRNA, the list of tissues where it is expressed, the predicted targets, the number of site on each target\'s transcript and the GO term associated to the targets are shown. Tissues legend: BCBL: Body cavity-based lymphoma, BL: Burkitt\'s lymphoma, PEL: Primary-effusion lymphoma. {#SD2}
===============================================================================================================================================================================================================================================================================================================================================================

  v-miRNA        Tissues         Target                                                    Sites   Target\'s GO terms
  -------------- --------------- --------------------------------------------------------- ------- ---------------------------------------------------------
  miR-K12-1      BCBL, BL, PEL   FOXO3A                                                    1       Pro-Apoptosis
  HBP1           1               Cell cycle arrest                                                 
  PDCD4          1               Negative regulation of cell cycle                                 
  PCDC6          1               Negative regulation of cell cycle                                 
  RBL1           1               Negative regulation of cell cycle                                 
  RAD1           1               Cell cycle checkpoint                                             
  TNFRSF10A      2               Pro-Apoptosis                                                     
  miR-K12-2      BCBL, BL, PEL   APC                                                       2       Negative Regulation of cyclin-dependent kinase activity
  CASP10a        1               Pro-Apoptosis                                                     
  CDKN2C         1               Cell cycle arrest                                                 
  CUL1           1               Cell cycle arrest                                                 
  CUL3           1               Pro-Apoptosis                                                     
  CUL5           1               Cell cycle arrest                                                 
  LATS2          1               Negative Regulation of cyclin-dependent kinase activity           
  MAPK1          1               Pro-Apoptosis                                                     
  RAD1           1               Cell cycle checkpoint                                             
  RBBP8          1               Cell cycle checkpoint                                             
  STK4           1               Pro-Apoptosis                                                     
  miR-K12-3      BCBL, BL, PEL   APBB1                                                     1       Cell cycle arrest
  APC            1               Negative Regulation of cyclin-dependent kinase activity           
  CDKN2B         1               Cell cycle arrest                                                 
  CUL5           2               Cell cycle arrest                                                 
  FAF1           1               Pro-Apoptosis                                                     
  RASSF1         1               Cell cycle arrest                                                 
  RBBP8          2               Cell cycle checkpoint                                             
  SMAD3          2               Cell cycle arrest                                                 
  STK3           1               Pro-Apoptosis                                                     
  STK4           3               Pro-Apoptosis                                                     
  miR-K12-4-5p   BCBL, BL, PEL   CCNG2                                                     1       Cell cycle checkpoint
  ING1           1               Negative regulation of cell cycle                                 
  RBL1           1               Negative regulation of cell cycle                                 
  ZAK            1               Cell cycle arrest                                                 
  miR-K12-6-3p   BCBL, BL, PEL   BID                                                       1       Pro-Apoptosis
  BTG3           1               Negative Regulation of mitotic cell cycle                         
  TBRG1          1               Cell cycle arrest                                                 
  miR-K12-7      PEL             ABL1                                                      1       Pro-Apoptosis
  miR-K12-9      PEL             FOXO4                                                     1       Cell cycle arrest
  TBRG1          1               Cell cycle arrest                                                 
  miR-K12-9\*    BCBL, BL, PEL   CASP8a                                                    1       Pro-Apoptosis
  TP53           1               Regulation of cell cycle                                          
  miR-K12-10a    BCBL, BL, PEL   CASP10a                                                   1       Pro-Apoptosis
  CASP10d        1               Pro-Apoptosis                                                     
  CUL2           2               Cell cycle arrest                                                 
  CUL4a          1               Cell cycle arrest                                                 
  EI24           1               Pro-Apoptosis                                                     
  FOXO4          1               Cell cycle arrest                                                 
  SMAD3          1               Cell cycle arrest                                                 
  miR-K12-10b    PEL             GAS7                                                      1       Cell cycle arrest
  miR-K12-11     BL              BCL10                                                     1       Pro-Apoptosis
  RB1            1               Negative regulation of cell cycle                                 
  RBL1           1               Negative regulation of cell cycle                                 
  APC            3               Negative Regulation of cyclin-dependent kinase activity           
  MPHOSPH1       1               Cell cycle arrest                                                 
  miR-K12-12     PEL             CASP10a                                                   1       Pro-Apoptosis

Supplementary Table S3.. Expression profiles of the predicted targets in infected cells. The profiles were retrieved from the NCBI GEO Profiles database. For each target, the GEO record ID, the virus, the mean value in the control sample (not infected), the mean value in the infected cell and the infected/control ratio are shown. Only values less than 1 are reported, since they indicate that the gene is under-expressed in the infected sample, compared to the control cell. {#SD3}
============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================

  Gene                    GEO Record                Virus     Mean (Control)   Mean (Infected)   Ratio (I/C)
  ----------------------- ------------------------- --------- ---------------- ----------------- -------------
  ABL1                    GDS989 - 1636_g\_at       EBV       5928.75          3531.80           0.59
  GDS989 - 39730_at       EBV                       5839.95   3504.20          0.60              
  GDS989 - 1635_at        EBV                       2786.60   1428.30          0.51              
  GDS940 - 202123_s\_at   KSHV                      406.35    246.35           0,60              
  APC                     GDS940 - 203525_s\_at     KSHV      110.60           63.90             0.57
  BCL10                   GDS940 - 205263_at        KSHV      637.50           439.55            0.68
  BID                     GDS940 - 204493_at        KSHV      263.25           140.40            0.53
  BTG3                    GDS940 - 213134_x\_at     KSHV      471.05           233.25            0.49
  CCNG2                   GDS989 - 1913_at          EBV       2690.40          1679.80           0.62
  GDS940 - 211559_s\_at   KSHV                      109.65    98.55            0.89              
  CDKN2C                  GDS940 - 204159_at        KSHV      116.10           68.95             0.59
  CUL1                    GDS940 - 207614_s\_at     KSHV      266.50           214.25            0.80
  CUL2                    GDS989 - 37894_at         EBV       817.95           454.50            0.55
  GDS940 - 203079_s\_at   KSHV                      254.00    164.40           0.64              
  CUL3                    GDS940 - 201371_s\_at     KSHV      766.05           533.75            0.69
  CUL4A                   GDS940 - 201423_s\_at     KSHV      270.50           208.75            0.77
  CUL5                    GDS940 - 203531_at        KSHV      323.30           256.55            0.79
  EI24                    GDS940 - 216396_s\_at     KSHV      349.60           202.05            0.57
  FAF1                    GDS940 - 218080_x\_at     KSHV      205.95           123.65            0.60
  FOXO3A                  GDS940 - 204132_s\_at /   KSHV      62.15            55.60             0.89
  HBP1                    GDS940 - 209102_s\_at     KSHV      281.35           274.65            0.97
  ING1                    GDS940 - 209808_x\_at     KSHV      73.90            61.05             0.82
  MAPK1                   GDS989 - 976_s\_at        EBV       1619.10          898.90            0.55
  GDS940 - 212271_at      KSHV                      750.10    399.50           0.53              
  MPHOSPH1                GDS940 - 205235_s\_at     KSHV      120.15           54.95             0.45
  RAD1                    GDS989 - 36857_at         EBV       2365.45          1954.6            0.82
  GDS940 - 204461_x\_at   KSHV                      176.50    77.55            0.43              
  GDS940 - 204460_s\_at   KSHV                      136.75    73.85            0.54              
  GDS940 - 210216_x\_at   KSHV                      158.55    102.85           0.64              
  RASSF1                  GDS940 - 204346_s\_at     KSHV      116.65           73.90             0.63
  RB1                     GDS989 - 2044_s\_at       EBV       1307.35          1149.60           0.87
  GDS940 - 203132_at      KSHV                      157.80    140.90           0.89              
  GDS940 - 211540_s\_at   KSHV                      50.60     44.70            0.88              
  RBBP8                   GDS940 - 203344_s\_at     KSHV      200.60           112.40            0.56
  SMAD3                   GDS940 - 205398_s\_at     KSHV      314.75           157.80            0.50
  STK3                    GDS940 / 208855_s\_at     KSHV      933.70           642.40            0.68
  STK4                    GDS940 - 211085_s\_at     KSHV      19.65            12.10             0.61
  TP53                    GDS989 - 1974_s\_at       EBV       1712.40          1561.70           0.91
  GDS989 - 1974_s\_at     KSHV                      1712.40   1530.25          0.89              
  GDS940 - 201746_s\_at   KSHV                      405.70    370.00           0.91              
  ZAK                     GDS940 - 218833_at        KSHV      42.50            30.25             0.71
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